Home
Search History
Clear History
{{item.search_key}}
Hot Searches
Change
{{item.name}}
{{item.english_name}}
Subscribe eNews
Once A Week Once Every Two Weeks
{{sum}}
{{sum}}
Log in

Please Login

Subscribe To Tags, See What You Want To See

Sign Up For Events, Expand your network

Unlock Private Messages, Participate In Interactions

 Register

Hi.{{userInfo.company_name_english||userInfo.truename_english}} Hi.{{userInfo.truename||userInfo.phone||userInfo.email}}

Applications

Carbon capture technology for sustainable beauty packaging

Clariant and partners demonstrate pyrolysis oil upgrading for circular plastics

Bekum to show packaging solutions for technically demanding markets at CHINAPLAS 2026

Products

AutoROCK digitizes extrusion: AI for error detection

Arkema expands Kynar PVDF production capacity in China

SONGWON adjusts global price for polymer stabilizers and coatings

Activities

  • Chinaplas2026 Preview Webinars | Smart Blow Moulding & AI Inspection (FREE)

  • CHINAPLAS 2026: Government blueprint for emerging industries driving new plastics innovation

  • Fakuma to celebrate 30th anniversary edition in October 2026

Pictorial

News Videos

Kingfa: Creation . Reproduce . Innovation

BASF: Next-generation solid-state battery pack unlocks electrical driven new dimension

Automatic 5L 120mm neck PET jar blowing machine

Conference Videos

【Mandarin session: Webinar playback】SACMI: Your Digitalized Manufacturing, Your Future Today

[Live Replay] LK Group: Smart Manufacturing, New Chapters in Southeast Asia: High-Efficiency Solutions in PET Preform & Thin-Wall Packaging

[Live Replay] Fu Chun Shin (FCS): Data-Driven Digital Rebirth and Intelligent Future of Injection Molding

Corporate/Product Videos

Guangdong Yilong Advanced Materials Technology Co Ltd

Mingsanfeng professional cap mould， Working together to pave the way for the growth of bottle cap molds.

QINGDAO BOUNI introduction video

News
NEW
HOT
 Events
NEW
HOT
 SPE Asia
NEW
HOT
 Special
NEW
HOT
 Live
NEW
HOT
 eNews
NEW
HOT
 Essential Guide
NEW
HOT
 Event Calendar
NEW
HOT
 Survey
NEW
HOT
 CHINA INSIGHT
NEW
HOT

Home > News > Medical

AI-for-science startup launches lab in Singapore to accelerate chemical discovery

Source：Adsale Plastics Network Date ：2025-12-08 Editor ：RC
Copyright： This article was originally written/edited by Adsale Plastics Network (AdsaleCPRJ.com), republishing and excerpting are not allowed without permission. For any copyright infringement, we will pursue legal liability in accordance with the law.

ChemLex, a next-generation AI-for-science startup, announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a US$45 million funding round led by Granite Asia, a leading multi-asset investment platform headquartered in Singapore.


ChemLex_logo.jpg


ChemLex is a next-generation AI-for-science startup.

 

ChemLex: Powering AI for drug discovery market

 

Founded in 2022, ChemLex develops AI technologies that radically accelerate chemical discovery for the pharmaceutical industry, significantly reducing time-to-market.

 

Only in its three-and-a-half-year operation, ChemLex has grown to support more than 70 customers worldwide, including six of the world's top ten pharmaceutical companies. This surge reflects a larger industry shift as analysts expect the AI-powered drug discovery market to jump from US$3.6 billion in 2024 to nearly US$50 billion by 2034.

 

At the core of ChemLex's platform is a 24/7 autonomous chemistry system that accelerates chemical discovery, making it far more cost-efficient and significantly more sustainable than traditional laboratory methods.

 

Driving this is an innovative AI-powered, fully automated synthesis line, which runs experiments autonomously, captures data in real-time, and transforms chemical discovery from a stop-start process into a smooth workflow.

 

“We're building an R&D engine that compresses months of synthesis and optimization into weeks or even days, transforming both the speed and certainty of discovery,” said Sean Lin, Founder and CEO of ChemLex.

 

Funding

 

The new funding will support the hiring of more hardware and software engineers, as well as chemists in Singapore, enabling the company to serve a broader pipeline of pharmaceutical and materials science projects.

 

“AI-enabled chemistry is creating one of the most important industrial transitions of the decade, and ChemLex sits in that sweet spot, turning that shift into a business advantage with a platform that can accelerate molecule design and manufacturing at scale. This is the type of deeptech company that can reshape supply chains, shorten development timelines, and unlock new economic value,” said Yinghui Kuang, Partner at Granite Asia.

 

Collaborating with national platform for drug discovery

 

ChemLex also signed a Memorandum of Understanding (MoU) with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development. As ChemLex's first Singapore partner, this collaboration seeks to accelerate next-generation small molecule drug discovery through advanced automation.

 

“This partnership reinforces our shared vision of accelerating drug discovery and development through cutting-edge technology, ultimately bringing safer, more effective therapies to patients faster. By combining EDDC's drug development expertise with ChemLex's automation and AI capabilities, we aim to shorten timelines, reduce costs, and deliver innovative treatments that improve lives in Singapore and globally,” commented Prof. Damian O'Connell of EDDC.

 


 Like 丨  {{details_info.likes_count}}
Singapore
ASEAN
AI

The content you're trying to view is for members only. If you are currently a member, Please login to access this content.   Log in

Source：Adsale Plastics Network Date ：2025-12-08 Editor ：RC
Copyright： This article was originally written/edited by Adsale Plastics Network (AdsaleCPRJ.com), republishing and excerpting are not allowed without permission. For any copyright infringement, we will pursue legal liability in accordance with the law.

ChemLex, a next-generation AI-for-science startup, announced the establishment of its global headquarters and self-driving laboratory in Singapore, alongside the close of a US$45 million funding round led by Granite Asia, a leading multi-asset investment platform headquartered in Singapore.


ChemLex_logo.jpg


ChemLex is a next-generation AI-for-science startup.

 

ChemLex: Powering AI for drug discovery market

 

Founded in 2022, ChemLex develops AI technologies that radically accelerate chemical discovery for the pharmaceutical industry, significantly reducing time-to-market.

 

Only in its three-and-a-half-year operation, ChemLex has grown to support more than 70 customers worldwide, including six of the world's top ten pharmaceutical companies. This surge reflects a larger industry shift as analysts expect the AI-powered drug discovery market to jump from US$3.6 billion in 2024 to nearly US$50 billion by 2034.

 

At the core of ChemLex's platform is a 24/7 autonomous chemistry system that accelerates chemical discovery, making it far more cost-efficient and significantly more sustainable than traditional laboratory methods.

 

Driving this is an innovative AI-powered, fully automated synthesis line, which runs experiments autonomously, captures data in real-time, and transforms chemical discovery from a stop-start process into a smooth workflow.

 

“We're building an R&D engine that compresses months of synthesis and optimization into weeks or even days, transforming both the speed and certainty of discovery,” said Sean Lin, Founder and CEO of ChemLex.

 

Funding

 

The new funding will support the hiring of more hardware and software engineers, as well as chemists in Singapore, enabling the company to serve a broader pipeline of pharmaceutical and materials science projects.

 

“AI-enabled chemistry is creating one of the most important industrial transitions of the decade, and ChemLex sits in that sweet spot, turning that shift into a business advantage with a platform that can accelerate molecule design and manufacturing at scale. This is the type of deeptech company that can reshape supply chains, shorten development timelines, and unlock new economic value,” said Yinghui Kuang, Partner at Granite Asia.

 

Collaborating with national platform for drug discovery

 

ChemLex also signed a Memorandum of Understanding (MoU) with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development. As ChemLex's first Singapore partner, this collaboration seeks to accelerate next-generation small molecule drug discovery through advanced automation.

 

“This partnership reinforces our shared vision of accelerating drug discovery and development through cutting-edge technology, ultimately bringing safer, more effective therapies to patients faster. By combining EDDC's drug development expertise with ChemLex's automation and AI capabilities, we aim to shorten timelines, reduce costs, and deliver innovative treatments that improve lives in Singapore and globally,” commented Prof. Damian O'Connell of EDDC.

 


全文内容需要订阅后才能阅读哦~
立即订阅
FUJIAN HONGKONG PETROCHEMICAL LIMITED KOKSAN CHINA POLYESTER CHIPS
ZHANGJIAGANG CITY FARCREATIVE PLASTIC MACHINERY CO., LTD Foaming Agent Series ANHUI ZHONGXIN HONGWEI TECHNOLOGY CO.,LTD

Recommended Articles

Medical
Dr. Boy machines to demonstrate high-precision medical components at CHINAPLAS 2026
 2026-03-09
Medical
Syensqo joins MedTech Innovator to support next generation medical device innovation
 2026-02-24
Medical
Syntegon launches AIM9 high-speed inspection platform for pharmaceutical sector
 2026-02-23
Medical
KRAIBURG TPE's medical-grade materials for otoscope device components
 2026-02-16
Medical
Lubrizol launches Tolerathane TPU for implantable medical devices
 2026-02-09
Medical
Covestro’s new TPU film on paper carrier unlocks medical device capabilities
 2026-02-03
Maguire Bannner Ad (EN) WENZHOU CHAOXU MACHINERY CO.，LTD.
JIANGYIN DELING GEARBOX CO.,LTD WENZHOU DETAI PLASTICS CO., LTD SSMMSS NONWOVEN LINE(SIX-BEAM)
  • Must See
    • News
    Images
    Watch it
1
Brückner showcases latest film stretching technologies at CHINAPLAS 2026
2
COACE highlights additives for photovoltaic and power battery sectors at CHINAPLAS 2026
3
Embossed, label-free PLA water bottle design for closed loop recycling
4
KRAIBURG TPE's medical-grade materials for otoscope device components
5
Syntegon launches AIM9 high-speed inspection platform for pharmaceutical sector
1
A visit to Bandera
2
Opening Ceremony of Bechton's New Factory
3
PVC-O160-400 Production Line Trial Run Video
4
QINGDAO BOUNI introduction video
5
Automatic 5L 120mm neck PET jar blowing machine
  • Hot Specials

You May Be Interested In

Change
  • People
  • Company
loading... No Content
{{[item.truename,item.truename_english][lang]}} {{[item.company_name,item.company_name_english][lang]}} {{[item.job_name,item.name_english][lang]}}
{{[item.company_name,item.company_name_english][lang]}} Company Name    {{[item.display_name,item.display_name_english][lang]}}  

Polyurethane Investment Medical Carbon neutral Reduce cost and increase efficiency CHINAPLAS Financial reports rPET INEOS Styrolution Evonik Borouge Polystyrene (PS) mono-material Sustainability Circular economy BASF SABIC Multi-component injection molding machine All-electric injection molding machine Thermoforming machine

AI-for-science startup launches lab in Singapore to accelerate chemical discovery

识别右侧二维码，进入阅读全文
下载
x 关闭
订阅
亲爱的用户，请填写一下信息
I have read and agree to the 《Terms of Use》 and 《Privacy Policy》
立即订阅
Top
Feedback
Chat
News
Market News
Applications
Products
Video
In Pictures
Specials
Activities
eBook
Front Line
Plastics Applications
Chemicals and Raw Material
Processing Technologies
Products
Injection
Extrusion
Auxiliary
Blow Molding
Mold
Hot Runner
Screw
Applications
Packaging
Automotive
Medical
Recycling
E&E
LED
Construction
Others
Events
Conference
Webinar
CHINAPLAS
CPS+ eMarketplace
Official Publications
CPS eNews
Media Kit
Social Media
Facebook
Linkedin
Adsale Group ｜  About Us ｜  Terms of Use ｜  Privacy Policy ｜  Contact Us ｜  Media Kit ｜  Consent Letter for Processing Personal Data ｜